Search alternatives:
significant barriers » significant barrier (Expand Search), significant factors (Expand Search), significant burden (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
barriers decrease » larger decrease (Expand Search), barrier disease (Expand Search)
significant barriers » significant barrier (Expand Search), significant factors (Expand Search), significant burden (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
barriers decrease » larger decrease (Expand Search), barrier disease (Expand Search)
-
2101
-
2102
ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side.
Published 2025Subjects: -
2103
-
2104
-
2105
-
2106
-
2107
-
2108
-
2109
-
2110
-
2111
-
2112
-
2113
-
2114
BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>.
Published 2025Subjects: -
2115
-
2116
-
2117
Modeling the relationship between cancer level in hemolymph and MarBTN in tank eDNA.
Published 2025Subjects: -
2118
-
2119
-
2120